Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.345 CAD -0.01 ( 2.82%)
Last update at 2026-11-05T20:46:00Z
VOLUME
314286
Market Cap
28.03M

Momentum Score

…

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.34
Low
0.38
High
52 Week Price Range
0.18
Low
0.42
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Diagnos Inc (ADK.V) is limited, which constrains definitive description of its operations. Disclosures indicate the company is an early-stage diagnostics developer and long-term growth drivers could include regulatory approvals, product validation and commercialization partnerships. Investors may find exposure to potential upside if the company successfully brings technology to market.
Material risks include an early-stage profile with limited operating history or revenue, dependence on regulatory and commercial execution, ongoing financing and dilution risk, and low trading liquidity.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.35
Dividend Yield
-
Revenue TTM
0.07M
Revenue Per Share
0.00
Gross Profit TTM
-1.43M
Debt / Equity
-1.04
ROE
-924.30%
Net Debt
2.80M
ROCE
-734.11%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -4.29M -3.12M -2.48M -2.61M -2.05M
Net income -4.29M -3.12M -2.48M -2.61M -2.05M
Selling general administrative 2.88M 1.77M 1.93M 2.24M 1.94M
Gross profit -0.94M -0.84M -0.31M -0.42M -0.35M
Reconciled depreciation 0.13M 0.12M 0.10M 0.11M 0.09M
Ebit - -2.60M - -2.55M -2.04M
Ebitda - -2.48M -2.10M -2.45M -1.93M
Depreciation and amortization - 0.12M - 0.10M 0.11M
Operating income -3.81M -2.60M -2.22M -2.55M -2.02M
Other operating expenses - 2.77M - 3.10M 2.55M
Interest expense 0.59M 0.55M 0.28M 0.05M 0.03M
Tax provision - - 0.00M 0.00M 0.00M
Interest income 0.05M 0.01M 0.01M 0.01M 0.02M
Net interest income -0.54M -0.54M -0.27M -0.05M -0.03M
Income tax expense - 0.00M - 0.15M 0.30M
Total revenue 0.10M 0.17M 0.49M 0.44M 0.27M
Total operating expenses 3.91M 1.76M 2.71M 2.24M 1.94M
Cost of revenue 1.05M 1.01M 0.79M 0.86M 0.61M
Total other income expense net 0.07M -0.52M 0.01M 0.10M 0.26M
Net income from continuing ops -4.29M -3.12M -2.48M -2.61M -2.05M
Net income applicable to common shares - - - -2.61M -2.05M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 3.64M 0.66M 0.82M 1.54M 1.95M
Other current assets - 0.02M 0.02M 0.02M 0.03M
Total liab 3.40M 3.72M 2.77M 1.66M 0.82M
Total stockholder equity 0.23M -3.05M -1.95M -0.11M 1.13M
Other current liab - 0.19M 0.01M 0.01M 0.00M
Common stock - 37.70M 35.91M 35.68M 34.76M
Capital stock 44.96M 37.70M 35.91M 35.68M 34.76M
Retained earnings -54.93M -50.65M -47.53M -44.99M -42.38M
Other assets - - - - 0.03M
Cash 0.09M 0.22M 0.30M 0.42M 0.36M
Total current liabilities 3.12M 1.62M 0.72M 0.66M 0.55M
Current deferred revenue - 0.01M - - -
Net debt 2.80M 2.97M 1.77M 0.54M -
Short term debt - 1.09M - - -
Short long term debt 2.69M 0.98M 0.17M 0.12M 0.12M
Short long term debt total - 3.19M - - -
Other stockholder equity - - 9.66M 9.20M 8.76M
Property plant equipment - - 0.25M 0.25M 0.33M
Total current assets 3.47M 0.41M 0.57M 1.29M 1.59M
Long term investments - - - 0.00M 0.03M
Net tangible assets - - - -0.11M 1.13M
Short term investments 3.15M - 0.00M 0.50M 1.00M
Net receivables 0.01M 0.17M 0.24M 0.33M 0.18M
Long term debt 0.20M 1.95M 1.90M 0.83M 0.04M
Accounts payable 0.17M 0.33M 0.29M 0.28M 0.19M
Accumulated other comprehensive income - 9.89M - - -
Non current assets total 0.17M 0.26M 0.25M 0.25M 0.36M
Capital lease obligations 0.18M 0.26M 0.24M 0.23M 0.31M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -3.10M -0.01M 0.50M 0.53M 0.30M
Change to liabilities - - -0.00M 0.12M 0.07M
Total cashflows from investing activities - - 0.47M 0.50M 0.26M
Net borrowings -0.38M - 1.40M 0.89M -0.21M
Total cash from financing activities 6.62M 2.35M 1.28M 1.60M 0.88M
Change to operating activities - - 0.01M 0.00M 0.10M
Net income -4.29M -3.12M -2.48M -2.61M -2.05M
Change in cash -0.13M -0.08M -0.12M 0.06M -0.21M
Begin period cash flow 0.22M 0.30M 0.42M 0.36M 0.57M
End period cash flow 0.09M 0.22M 0.30M 0.42M 0.36M
Total cash from operating activities -3.64M -2.41M -1.88M -2.04M -1.36M
Issuance of capital stock 7.28M 1.64M 0.45M 0.72M 1.11M
Depreciation 0.13M 0.12M 0.10M 0.11M 0.09M
Other cashflows from investing activities - - -0.00M 0.00M 0.01M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory - - - 0.00M -0.12M
Change to account receivables -0.00M 0.10M 0.08M -0.14M 0.14M
Other cashflows from financing activities - -0.01M -0.12M 0.98M 0.02M
Change to netincome - - 0.39M 0.48M 0.30M
Capital expenditures 0.01M 0.01M 0.02M 0.03M 0.04M
Change in working capital -0.24M 0.15M 0.09M -0.01M 0.31M
Stock based compensation 0.29M 0.18M 0.17M 0.17M 0.43M
Other non cash items 0.29M 0.52M 0.12M 0.03M 0.03M
Free cash flow -3.65M -2.42M -1.91M -2.07M -1.40M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ADK
Diagnos Inc
-0.01
2.82%
0.34 - 10.00 411.24 18.74 389.06 -6.16
NURS
Hydreight Technologies Inc
0.14
4.98%
2.95 406.00 25.91 7.85 20.38 7.45 109.02
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 72.08 -0.81
CHS
Comprehensive Healthcare Systems Inc
-0.03
7.69%
0.30 - - 4.44 13.23 3.83 26.88

Profile*

Diagnos Inc

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialist to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7

450 678 8882

Name Title Year Born
Mr. Andre Larente CEO, Pres & Exec. Director NA
Mr. Marc-André Massue VP of Fin., CFO & Sec. NA
Mr. Guillermo Moreno Robles VP of Sales NA
Mr. Martin Beland Director of Marketing NA
Mr. Andre Larente CEO, President & Executive Chairman NA
Mr. Marc-André Massue VP of Finance, CFO & Secretary NA
Mr. Yves-Stéphane Couture Chief Operating Officer NA
Mr. Marc-André Massue CA, CPA VP of Finance, CFO & Secretary NA
Mr. Andre Larente CEO, President & Executive Director NA
Dr. Ismail Ben Ayed Chief Artificial Intelligence Scientist NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…